ONCOSIL MEDICAL LTD

ASX: OSL

Sector: Sector:Health Care
Industry group: Industry:Pharmaceuticals, Biotechnology & Life Sciences

Latest OSL ASX Announcements

30 Sept 2026 · 9:27 amCompany Update
OncoSil Clinical Data to be Presented at EANM 2026
30 Sept 20269:27 amOncoSil Clinical Data to be Presented at EANM 2026Company Update
28 Sept 2026 · 1:26 pmMeetings & Governance
Notice of AGM date
28 Sept 20261:26 pmNotice of AGM dateMeetings & Governance
15 Sept 2026 · 9:04 amSecurities Administration
Notice under ASX Listing Rule 3.10A
15 Sept 20269:04 amNotice under ASX Listing Rule 3.10ASecurities Administration
14 Sept 2026 · 4:52 pmSubstantial Holders
Change in substantial holding
14 Sept 20264:52 pmChange in substantial holdingSubstantial Holders
14 Sept 2026 · 8:39 amSubstantial Holders
Change in substantial shareholding from AEF
14 Sept 20268:39 amChange in substantial shareholding from AEFSubstantial Holders
10 Sept 2026 · 11:21 amSecurities Administration
Notice Under Section 708A
10 Sept 202611:21 amNotice Under Section 708ASecurities Administration
10 Sept 2026 · 11:20 amSecurities Administration
Application for quotation of securities - OSL
10 Sept 202611:20 amApplication for quotation of securities - OSLSecurities Administration
10 Sept 2026 · 11:16 amSecurities Administration
Application for quotation of securities - OSL
10 Sept 202611:16 amApplication for quotation of securities - OSLSecurities Administration
9 Sept 2026 · 8:43 amCompany Update
Australian Manufacturing Facility Achieves ISO 13485
9 Sept 20268:43 amAustralian Manufacturing Facility Achieves ISO 13485Company Update
8 Sept 2026 · 9:40 amCompany Update
100th Patient Treated with OncoSil device in Spain
8 Sept 20269:40 am100th Patient Treated with OncoSil device in SpainCompany Update
7 Sept 2026 · 5:12 pmSecurities Administration
Proposed issue of securities - OSL
7 Sept 20265:12 pmProposed issue of securities - OSLSecurities Administration
7 Sept 2026 · 5:11 pmCapital Raising
OSL Secures $5.6 million from Major Institutional Investors
7 Sept 20265:11 pmOSL Secures $5.6 million from Major Institutional InvestorsCapital Raising
2 Sept 2026 · 11:33 amCompany Update
OncoSil submits US Reimbursement Application (Updated)
2 Sept 202611:33 amOncoSil submits US Reimbursement Application (Updated)Company Update
2 Sept 2026 · 10:27 amCompany Update
OncoSil submits US Reimbursement Application
2 Sept 202610:27 amOncoSil submits US Reimbursement ApplicationCompany Update
28 Aug 2026 · 4:03 pmCompany Administration
Appendix 4G and Corporate Governance Statement
28 Aug 20264:03 pmAppendix 4G and Corporate Governance StatementCompany Administration

View complete OSL announcement history →